September 2014
Issue 69
Kerri Sparling (Sixuntilme.com) discusses CGM in the Cloud, explaining what it is and how it works. Sparling writes about its benefits and drawbacks that are leading to a split in the diabetes community - some people are celebrating its attributes while others are keeping their distance. 

Articles

Abbott’s Freestyle Libre launches in Europe, a new obesity medication clears an FDA hurdle, and more!

The curious milestone of a diabetes anniversary. 

What are the most solvable problems in diabetes? 

Could Tidepool’s software change type 1 diabetes?

Will a combination of type 2 drugs prove significantly better than one alone?

(S)he said what?!?

Hoping for an oral insulin – but why stop there?

Syndicate content